ERBB2 and breast cancer: To better understand the role of E‐selectin ligands in IDC pathogenesis, a diverse group of primary cells with a broad expression of breast cancer standard markers, such as estrogen receptor, progesterone receptor, HER2, Ki67, and cytokeratin 5, was established (Table 2).